Business
2 blue chip ASX 200 shares that could be strong buys
If you’re aiming to build a balanced portfolio, having a few blue chip ASX shares in there could be a smart move.
But which blue chip ASX 200 shares should you buy? Two that are highly rated are listed below:
The first blue chip ASX 200 share to look at is biotechnology giant CSL.
CSL has a focus on rare and serious diseases through its CSL Behring business and influenza vaccines through its Seqirus business.
CSL Behring has a wide range of innovative therapies. These are used to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological disorders. Whereas Seqirus has a broad range of flu products meeting the needs of different populations around the world.
While…
-
Noosa News19 hours agoPhotographer Nadia Shevtsova remembered by family in touching tribute after deadly crash at Gold Coast
-
General10 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General13 hours agoMajority of Australia’s first Ashes Test squad to feature in Sheffield Shield round four
-
Noosa News21 hours agoWoman’s lucky escape after car rolls and crashes onto tracks before being hit by oncoming train in Kingston, Logan